The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other academic cancer ...
Dec 11, 2023
0
0
Older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who were not good candidates for the standard treatment of intensive chemotherapy had a median overall survival (OS) of 6.5 years ...
Dec 11, 2023
0
0
University at Buffalo research has identified how a misstep in the genesis of a key component of the kidney causes infantile cystinosis, a rare disease that significantly shortens the lifespan of patients.
Dec 8, 2023
0
0
The Centers for Disease Control and Prevention and Mayo Clinic recommend a yearly flu vaccination for everyone six months and older, with rare exceptions. Vaccination is your best defense against flu. If you haven't gotten ...
Dec 8, 2023
0
4
A woman with hopes to conceive was diagnosed with severe vasospastic angina (VSA); however, she was able to carry a healthy baby to full term without angina attacks after starting treatment of a calcium channel blocker, according ...
Dec 6, 2023
0
0
The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday.
Dec 6, 2023
0
3
Much attention has recently focused on the use of opioids, which include morphine and related painkillers such as oxycodone. Though regarded as a blessing for patients suffering from severe and acute pain, they can also be ...
Dec 5, 2023
0
0
The BASHIR Endovascular Catheter (THROMBOLEX, Inc.), recently approved by the U.S. Food and Drug Administration (FDA), is paving the way to more effective and safe treatment for acute pulmonary embolism.
Dec 4, 2023
0
1
In a study published in the journal Genes & Diseases, researchers from Beckman Research Institute of City of Hope, explored the impact of m6A modification on the maturation process of precursor microRNAs (pre-miRNAs) and ...
Dec 4, 2023
0
1
In a recent study, scientists led by Professor Stefan Müller from Goethe University's Institute of Biochemistry II investigated a specific form of blood cancer known as acute myeloid leukemia, or AML. The disease mainly ...
Dec 4, 2023
0
15
